Brepocitinib Tosylate is the tosylate form of brepocitinib, an orally available, selective inhibitor of non-receptor tyrosine-protein kinase TYK2 (tyrosine kinase 2) and tyrosine-protein kinase JAK1 (Janus kinase 1; JAK1), with potential immunomodulatory and anti-inflammatory activities. It is grouped under the following drug class(es): Tyrosine Kinase Inhibitors. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Methanone, ((1S)-2, 2-difluorocyclopropyl)(3-(2-((1-methyl-1H-pyrazol-4-yl)amino)-4-pyrimidinyl)-3, 8-diazabicyclo(3.2.1)oct-8-yl)- and 4-methylbenzenesulfonate (1:1). Its PubChem CID is 124203834.
Brepocitinib tosylate
| CAS No | 2140301-96-6 |
|---|---|
| Molecular Formula | C25H29F2N7O4S |
| Molecular Weight | 561.6 g/mol |
| Synonyms | [(1S)-2,2-difluorocyclopropyl]-[(1S,5R)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone;4-methylbenzenesulfonic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Brepocitinib Tosylate is the tosylate form of brepocitinib, an orally available, selective inhibitor of non-receptor tyrosine-protein kinase TYK2 (tyrosine kinase 2) and tyrosine-protein kinase JAK1 (Janus kinase 1; JAK1), with potential immunomodulatory and anti-inflammatory activities.
The listed CAS number is 2140301-96-6.
The listed molecular formula is C25H29F2N7O4S.
The listed molecular weight is 561.6 g/mol.
[(1S)-2,2-difluorocyclopropyl]-[(1S,5R)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone;4-methylbenzenesulfonic acid.
The source lists Methanone, ((1S)-2, 2-difluorocyclopropyl)(3-(2-((1-methyl-1H-pyrazol-4-yl)amino)-4-pyrimidinyl)-3, 8-diazabicyclo(3.2.1)oct-8-yl)- and 4-methylbenzenesulfonate (1:1).